Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2025 ,inter alia, to consider and approve Split/ Sub division ....
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Ltd has informed the exchanges that its Board of Directors will meet on Monday, July 28, 2025 via video conferencing. The key item on the agenda is to consider and approve the sub-division or split of existing equity shares of the company, under Section 61 of the Companies Act, 2013. The company, formerly known as Fischer Chemic Limited, is registered in Visakhapatnam and listed on both BSE (Scrip Code: 524743) and NSE (Symbol: FISCHER). The trading window for dealing in shares is already closed for designated persons and will remain closed until 48 hours after the declaration of financial results for Q1FY26.
A stock split makes shares more affordable and can improve liquidity, potentially attracting more retail investors. Shareholders may see an increase in the number of shares held, though the overall value of their holding remains unchanged. Investors should watch for the split ratio announcement post the board meeting.